Contact Us | Print Page | Sign In | Register
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Industry News for MS (INforMS)
Thursday, October 11, 2018
CMSC InforMS: TG Therapeutics, Inc. Announces Final Phase 2 MS Data Presentation at ECTRIMS »
Annualized Relapse Rate (ARR) of 0.07 observed for all patients on Phase 2 trial   ECTRIMS data review conf...
Wednesday, September 5, 2018
CMSC INforMS: Researchers Identify New Subtype of Multiple Sclerosis »
Researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the disease and...
Wednesday, August 29, 2018
CMSC INforMS: MRI Tests May Help Doctors Predict MS Progression in Patients »
Researchers may have figured out how to use information from these imaging tests to determine what type of multiple sclero...
Thursday, August 9, 2018   (0 Comments - view/add)
CMSC INforMS: Researchers Have a New Theory About What May Cause Multiple Sclerosis »
When the following headline in the Australian newspaper the Herald Sun caught my eye recently, I was cautiously intrig...
Monday, July 30, 2018   (0 Comments - view/add)
CMSC INFORMS: FDA Accepts File for Cladribine Tablets as Potential Tx for Relapsing Forms of MS »
PDF   ROCKLAND, Mass., July 30, 2018 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Ger...

CMSC Outreach
Friday, September 28, 2018   (0 Comments - view/add)
OUR CONDOLENCES TO THE FAMILY OF NICOLA "NICKI" WARD-ABEL, RGN, BSc (Hons), MSCN »
It is with a heavy heart that IOMSN announces the passing of Nicola "Nicki" Ward-Abel. Nicki was a  founding member...
Monday, August 13, 2018
CMSC Outreach: Call for Test Sites: Using Patient-Reported Outcomes to Drive Multiple Sclerosis Care »
Researchers at Northwestern University are seeking volunteers to participate in the pilot testing of a new quality measu...
Wednesday, April 18, 2018
CMSC Outreach: Imagerywork »
Dr. Miriam Franco , PSY.D, MSCS, has developed a new APP that includes a separate page for Guided Imagery for MS, Improvi...
Tuesday, February 6, 2018
CMSC Outreach: Caregivers Bill Supports Patients with Multiple Sclerosis »
President Donald Trump recently signed the Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act (...
Wednesday, June 28, 2017   (0 Comments - view/add)
CMSC Outreach: IJMSC Wins 2017 APEX Award »
The  International Journal of MS Care  has received an Award of Excellence in the APEX 2017 Awards for Publicati...

New from our Partners
Tuesday, December 18, 2018   (0 Comments - view/add)
News from our Partners: FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive MS »
NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of inn...
Friday, October 12, 2018
New from our Partners: Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, »
Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, Evobrutinib in RMS   Fir...
Wednesday, October 10, 2018
News from our Partners: Novartis announces FDA filing acceptance of siponimod (BAF312) »
Novartis announces FDA filing acceptance of siponimod (BAF312), the first and only oral drug shown to delay disability pro...
Wednesday, October 10, 2018
News from our Partners: Press Release - New Efficacy and Safety Data on MS Portfolio to be Presented »
New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018   Late-breaking Phase I...
Wednesday, October 10, 2018
News from our Partners: Press Release - Ocrevus data show early initiation reduces progression »
PRESS RELEASE: OCREVUS (OCRELIZUMAB) DATA SHOW EARLY INITIATION OF TREATMENT REDUCES DISABILITY PROGRESSION OVER FIVE YEAR...

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org